Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Novel Sigma-1 Receptor Antagonist in Three Randomized Phase I Studies

British Journal of Clinical Pharmacology, 06/08/2012

S1RA exhibited acceptable safety, tolerability, pharmacodynamic, and pharmacokinetic profiles in healthy subjects over the dose range studied.

Print Article Summary Cat 2 CME Report